시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 장골 스텐트 시장 보고서(2025년)
Iliac Stent Global Market Report 2025
상품코드 : 1704579
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,371,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,209,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,048,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

장골 스텐트 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 6.9%의 CAGR로 14억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 말초 동맥 질환의 유병률 증가, 노인 인구의 증가, 혈관성형술의 증가, 덜 침습적인 수술의 필요성 증가, 당뇨병 유병률 증가 등에 기인합니다. 예측 기간 동안 주요 동향으로는 장골 스텐트 기술 발전, 제품 승인 증가, 의료 기술 발전, 유통망 확대, 외래 환자 대상 장골 스텐트 채택 등이 있습니다.

말초동맥질환의 유병률 증가는 당분간 장골 스텐트 시장의 성장을 견인할 것으로 예상됩니다. 말초동맥질환(PAD)은 심장이나 뇌 이외의 동맥이 좁아지거나 막히는 것을 특징으로 하는 혈관 질환으로, 흡연, 고령화, 고혈압, 당뇨병 등의 요인에 기인하는 경우가 많습니다. 장골 스텐트삽입술은 PAD 환자들에게 혈류 개선, 증상 완화, 합병증 감소를 가져다주며, 이 모든 것이 최소침습적이고 높은 성공률을 자랑합니다. 예를 들어, 2023년 7월 심혈관조영 및 중재시술학회 자료에 따르면, PAD는 매년 800만-1,000만 명의 미국인이 앓고 있으며, 2050년에는 1,900만 명의 미국인이 PAD를 앓게 될 것으로 예측됩니다. 따라서 말초동맥질환의 유병률 증가는 장골 스텐트 시장의 원동력이 되고 있습니다.

장골 스텐트 시장의 주요 업체들은 환자의 예후를 개선하고 합병증 가능성을 줄이기 위해 iCast와 같은 제품 혁신에 전념하고 있으며, iCast로 덮인 스텐트 시스템은 장골 동맥 폐쇄성 질환에 대처하는 새로운 접근 방식을 의미합니다. 우수한 성능과 합병증 위험 감소를 제공합니다. 예를 들어, 2023년 10월 Getinge는 장골동맥 폐쇄성 질환 치료제로 FDA 승인을 받은 iCast-covered 스텐트 시스템을 미국에서 시판한다고 발표했습니다. 이번 개발은 미국 임상의와 병원 시스템에 이 심각한 질환을 효과적으로 관리할 수 있는 최고 수준의 제품과 지원을 제공하겠다는 Getinge의 약속을 강조하는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Iliac stents are specialized medical devices crafted to address atherosclerosis in the iliac arteries, situated in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to widen and provide support to narrowed or obstructed arteries.

The primary types of iliac stents include self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical instruments utilized for treating narrowed or obstructed blood vessels in various parts of the body, including the coronary arteries, peripheral arteries, and other tubular structures. They are employed in the treatment of various artery lesions such as common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. These stents are utilized by a range of end-users including hospitals, outpatient facilities, and others.

The iliac stent market research report is one of a series of new reports from The Business Research Company that provides iliac stent market statistics, including iliac stent industry global market size, regional shares, competitors with an iliac stent market share, detailed iliac stent market segments, market trends, and opportunities, and any further data you may need to thrive in the iliac stent industry. This iliac stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iliac stent market size has grown strongly in recent years. It will grow from $1.02 billion in 2024 to $1.09 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to expansion of the global healthcare industry, increased awareness about minimally invasive procedures, increased demand for stenting procedures, rise in incidence of iliac artery diseases, improved healthcare infrastructure.

The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.43 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing prevalence of peripheral artery diseases, growing geriatric population, increasing angioplasty operations, rise in the need for less intrusive operations, rising incidence of diabetes. Major trends in the forecast period include technological advancements in iliac stents, increasing number of product approvals, advancements in medical technology, expanding distribution networks, adoption of iliac stents in outpatient settings.

The increasing incidence of peripheral artery diseases is anticipated to drive the expansion of the iliac stent market in the foreseeable future. Peripheral artery disease (PAD) is a vascular condition characterized by the narrowing or blockage of arteries outside the heart and brain, often attributed to factors such as smoking, an aging population, hypertension, and diabetes. Iliac stenting emerges as a valuable treatment modality for PAD patients, offering enhanced blood flow, relief from symptoms, and mitigation of complications, all while being minimally invasive and boasting a high success rate. For instance, as per data from the Society for Cardiovascular Angiography and Interventions in July 2023, PAD affects 8-10 million Americans annually, with projections estimating 19 million Americans to be affected by PAD by 2050. Hence, the escalating prevalence of peripheral artery diseases serves as a driving force for the iliac stent market.

Key players in the iliac stent market are dedicated to innovating products such as iCast to elevate patient outcomes and diminish the likelihood of complications. The iCast-covered stent system signifies a novel approach to addressing iliac artery occlusive disease, offering superior performance and a reduced risk of complications compared to conventional bare-metal stents. For instance, in October 2023, Getinge announced the US commercial availability of the iCast-covered stent system, FDA-approved for treating iliac arterial occlusive disease. This development underscores Getinge's commitment to furnishing US clinicians and hospital systems with top-tier products and support for managing this critical condition effectively.

In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems Inc. (CSI) for an undisclosed sum. This strategic move by Abbott Laboratories aims to enrich its vascular device portfolio by integrating CSI's innovative atherectomy system. Cardiovascular Systems Inc. is renowned for its contributions in the realm of medical technology, particularly in manufacturing iliac stents.

Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH

North America was the largest region in the iliac stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iliac stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iliac Stent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iliac stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for iliac stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The iliac stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Iliac Stent Market Characteristics

3. Iliac Stent Market Trends And Strategies

4. Iliac Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Iliac Stent Growth Analysis And Strategic Analysis Framework

6. Iliac Stent Market Segmentation

7. Iliac Stent Market Regional And Country Analysis

8. Asia-Pacific Iliac Stent Market

9. China Iliac Stent Market

10. India Iliac Stent Market

11. Japan Iliac Stent Market

12. Australia Iliac Stent Market

13. Indonesia Iliac Stent Market

14. South Korea Iliac Stent Market

15. Western Europe Iliac Stent Market

16. UK Iliac Stent Market

17. Germany Iliac Stent Market

18. France Iliac Stent Market

19. Italy Iliac Stent Market

20. Spain Iliac Stent Market

21. Eastern Europe Iliac Stent Market

22. Russia Iliac Stent Market

23. North America Iliac Stent Market

24. USA Iliac Stent Market

25. Canada Iliac Stent Market

26. South America Iliac Stent Market

27. Brazil Iliac Stent Market

28. Middle East Iliac Stent Market

29. Africa Iliac Stent Market

30. Iliac Stent Market Competitive Landscape And Company Profiles

31. Iliac Stent Market Other Major And Innovative Companies

32. Global Iliac Stent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Iliac Stent Market

34. Recent Developments In The Iliac Stent Market

35. Iliac Stent Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기